|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0017262,
umls-concept:C0033522,
umls-concept:C0069515,
umls-concept:C0079419,
umls-concept:C0080103,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205210,
umls-concept:C0441767,
umls-concept:C0549193,
umls-concept:C1512083,
umls-concept:C1704824,
umls-concept:C2911684
|
|
pubmed:issue |
1B
|
|
pubmed:dateCreated |
1998-5-13
|
|
pubmed:abstractText |
The association between p53 and c-erbB-2 overexpression relation to ER status in ductal breast carcinoma is still unclear. Our aim was investigate the prognostic importance of the overexpression of c-erbB-2, p-53 factor, and ER status in stage II of human ductal breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
619-23
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:9568187-Adult,
pubmed-meshheading:9568187-Aged,
pubmed-meshheading:9568187-Breast Neoplasms,
pubmed-meshheading:9568187-Carcinoma, Ductal, Breast,
pubmed-meshheading:9568187-Female,
pubmed-meshheading:9568187-Humans,
pubmed-meshheading:9568187-Immunohistochemistry,
pubmed-meshheading:9568187-Middle Aged,
pubmed-meshheading:9568187-Neoplasm Recurrence, Local,
pubmed-meshheading:9568187-Prognosis,
pubmed-meshheading:9568187-Prospective Studies,
pubmed-meshheading:9568187-Receptor, erbB-2,
pubmed-meshheading:9568187-Receptors, Estrogen,
pubmed-meshheading:9568187-Tumor Suppressor Protein p53
|
|
pubmed:articleTitle |
Prospective studies of p53 and c-erbB-2 expression in relation to clinicopathological parameters of human ductal breast cancer in the second stage of clinical advancement.
|
|
pubmed:affiliation |
Silesian Center of Oncology, Wroclaw, Poland.
|
|
pubmed:publicationType |
Journal Article
|
